Home
/ Imugene
/ Competitors

Imugene Competitors and Similar CompaniesClear all

Imugene's competitors and similar companies include Fluxion Biosciences, Ecrins Therapeutics, MicrobiomeDX and AstraZeneca.

	Imugene Imugene is a clinical-stage immuno-oncology company developing cancer treatments.	Fluxion Biosciences Fluxion Biosciences is a company developing systems for live cell analysis.	Ecrins Therapeutics Ecrins Therapeutics is a biotechnology company that focuses on the discovery and development of anti-cancer compounds.	MicrobiomeDX MicrobiomeDX is a company that develops cancer immunotherapies.	AstraZeneca AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.
Founding Date	Founding Date 2013	Founding Date 2005	Founding Date 2010	Founding Date 2017	Founding Date 1999
Type	Type Public	Type Private	Type Private	Type Private	Type Public
Tags	Tags Healthcare biotech clinical research drug development oncology	Tags Healthcare biotech clinical research drug development oncology	Tags Healthcare biotech clinical research drug development oncology	Tags Healthcare biotech clinical research drug development oncology	Tags Healthcare biotech clinical research drug development oncology pharma
Locations	Locations SYDNEY, AU HQ	Locations Alameda, US HQ	Locations La Tronche, FR HQ	Locations Houston, US HQ	Locations Cambridge, GB HQ Alger, DZ Buenos Aires, AR Macquarie Park, AU Macquarie Park, AU North Ryde, AU Wien, AT see more
Employees	Employees N/A	Employees 7	Employees 1	Employees 1	Employees 94,300
Valuation ($)	Valuation ($) 247 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 2.7 b
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $58.7b (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods $4.9b (FY, 2025)
Gross profit	Gross profit $4.4m (FY, 2025)	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit $54.2b (FY, 2025)
Net income	Net income ($69m) (FY, 2025)	Net income N/A	Net income N/A	Net income N/A	Net income $10.2b (FY, 2025)
Funding
Latest funding round	Latest funding round N/A	Latest funding round $ 280k (over 6 years ago)	Latest funding round $ 599.1k (almost 11 years ago)	Latest funding round N/A	Latest funding round N/A
Total funding raised	Total funding raised N/A	Total funding raised $ 22.5m	Total funding raised $ 2.7m	Total funding raised N/A	Total funding raised $ 1b